Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(153)
•••
Comment by newdaydawningon Jan 13, 2020 7:43pm
199 Views
Post# 30548833

RE:RE:Mineking correctly called the trade warrants - THANK YOU!!

RE:RE:Mineking correctly called the trade warrants - THANK YOU!!Fear not, my friend. TLT is poised to take off BIG TIME in 2020. Let's just start with what everybody forgets - 2-YR CR on P5 and P6 from phase one.

We all know the good news coming next and just as you urged me to buy the warrants, I would advise you to adopt a long and strong view with your TLT holdings.

TLT is set to become the next QLT in the hall of game of Canadian biotechs - DYOD.

Mineking66 wrote: Thats awesome. Thats why Theralase needs higher stock prices.. to get warrants exercised to bring in more cash.. This is my only Canadian stock play left..even though I have lived here all of my 50 years..it saddens me.. 2020 is on track already to be the year of the biotechs and I truly hope this Theralase gets carried along for the ride..


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities